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INTRODUCTION 
Psychosomatic medicine emphasizes the unity of mind and body and the 
interaction between them. The general notion is that psychological factors are 
important in the development of all diseases. The history of psychosomatic 
medicine has its roots in ancient beliefs that the body can be affected by 
external forces. For example, in Bible (Isamuel 5:4-38) ‘Nabal’ has been 
regarded the first recorded psychosomatic death from myocardial infarction. 
‘Walter canon’ in the early part of the twentieth century conducted first 
systematic study of the relation of stress to disease. Harold Wolft, Hans selye, 
Helen Deutsch, Adolph Mayer, Leven Eisenberg were among the few who 
contributed much to the psychosomatic medicine. 
According to the contemporary psychiatric research, Mind or body 
responds not only to biological factors but also to the social factors.  
Psychosomatic medicine includes a wide range of diseases, but the most 
common diseases include those affecting the gastro intestinal, respiratory, 
endocrine and cutaneous system. 
A relationship between dermatological conditions and psychological 
factors has long been observed. It has been estimated that approximately a 
third of the patients presenting with dermatological disorders have some 
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psychological comorbidity (Rostenberg, 1960). Several possible mechanisms 
explain this association. The dermis and brain share a common embryological 
origin. Also, because the skin is exposed to view, dermatological conditions 
that affect appearance may elicit reaction from other people that has impact on 
the sufferer (Van moffaert, 1992). 
The term psychocutaneous disorder describes several distinct psychiatric 
disorders in which the skin is affected. Koblenzer (1999) has proposed that 
these conditions can be loosely grouped into: 
• Psychiatric disorders in which the skin is the focus of symptoms. 
• Dermatological disorders in which psychological distress 
contributes to the degree of severity. 
• Psychiatric disorders secondary to chronic dermatological or 
disfiguring conditions. 
SKIN DISORDERS 
Among the various psychosomatic diseases, skin diseases are the most 
important because of the following factors 
i) Skin does more than presenting one’s face to the world. As our most 
ancient interface, skin retains the ability to respond to both 
exogenous and endogenous stimuli, sensing and integrating 
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environmental cues while transmitting intrinsic condition to the 
outside world (Richard 1988). 
ii) Sulzberger (1983) stated that of all illnesses, skin diseases affect the 
mind the most and can be a great handicap in work and social 
settings. The recognition and management of psychological factors 
have become part of dermatological practice because of the complex 
interaction between the skin and psyche. 
Psoriasis 
 Psoriasis is an inflammatory, non infectious proliferative disease of the 
skin characterized by chronic well defined scaly plaques, predominantly on the 
extensor aspect of the body and scalp. Incidence may range from 0.1-2.8% 
(Ginsburg, 1989). 
The disease can virtually affect any age group. The course of the disease 
is unpredictable, but it is usually chronic with exacerbations and remissions. 
Exact etiology is unknown but the factors involved may be genetic, 
biochemical and immunopathological ones. Precipitating factors include 
trauma, infection, sunlight, drugs and emotion. Various types like 
palmoplantar, psoriasis vulgaris, pustular, guttate, and elephantine and 
erythrodermic varieties have been described. Treatment is mainly in the form 
of topical steroids, PUVA, methotrexate and tazoretene and retinoids.  
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Although many skin diseases produce psychological morbidity, only 
psoriasis is chosen because, 
i) Prevalence of psychiatric morbidity is high in psoriasis and only 
few Indian studies are available. (Mattoo, sharma 2001). 
ii) Stressful life events may exacerbate psoriasis, acne, eczema and 
urticaria. Among the above mentioned discussions, only psoriasis 
has shown consistent association with stress.  
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AIM AND HYPOTHESIS 
 
AIM  
The aim of the study is to know the prevalence of psychiatric morbidity 
and stressful life events in psoriasis, to correlate with socio demographic 
variables and to know their clinical relevance. 
HYPOTHESIS  
• Prevalence of psychiatric disorders are high (especially depression) in 
patients with psoriasis.  
• Stressful life events are common in patients with psoriasis, especially 
events occurring within a year. 
• Psychiatric morbidity is high in psoriatic patients, who are exposed to 
more stressful life events within a year. 
• Psychiatric morbidity is more common in patients with long duration of 
psoriasis.   
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REVIEW OF LITERATURE 
Stress is one of the central concepts of psychiatry. All people share an 
existential vulnerability to life’s difficulties. The classical Greeks would have 
it, “we are all but a heartbeat away from the disaster”. Stress has been invoked 
as a precipitator or trigger of psychiatric illness, a contributor to considerable 
mental anguish and a cause of major psychopathology.  
The field of Psychodermatology or Psychocutaneous medicine focuses 
on the interaction between the mind, the brain, and the skin. Skin is not only 
the largest organ of the body but also an organ of expression, and it responds to 
emotions with blushing, pallor, piloerection, and perspiration. Brain and skin 
originate from the same germ layer, the embryonic ectoderm, and are affected 
by the same hormones and neurotransmitters. Psychopathological factors can 
play an etiological role in the development of skin disorders and exacerbate 
pre-existing skin disorders. Dermatology patients suffer from the psychosocial 
consequences of disfigurement. Psychodermatology as a discipline encourages 
a comprehensive and humanistic approach to the management of dermatology 
patients with psychiatric comorbidity. 
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STRESS AND PSYCHIATRY – HISTORICAL ASPECTS 
The term Stress was coined by Hans Selye (1907 to 1982). He observed 
that many highly diverse ways of perturbing the organism resulted in common 
physiological responses. He reported that there is a “general adaptation 
system”, a systemic well-orchestrated adaptive response to diverse stressors. 
He observed that any novelty or perturbation was associated with an elevation 
of adrenocortical activity, at least transiently, and that if stressors were 
unremitting, diverse pathological changes would be evident. 
The other groundbreaker in the field of stress research was Walter 
Cannon (1871 to 1945). He was acclaimed for his methodical investigations of 
the sympathetic nervous system. He also focused on more immediate or short-
term responses to stressors. William Harvey in the 17th century and William 
Osler in the 19th century frequently alluded to the relationship between adverse 
life events and onset of illness. 
PSYCHOLOGICAL MEASUREMENT OF STRESS 
Regardless of whether stress is a cause or trigger and regardless of 
whether one focuses on stress or the factors that affect resilience to stress, the 
key step is to recognize and in some way quantify its extent. 
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Approximately 80 years ago, Adolf Meyer suggested that psychiatrists 
employ a “life chart” in evaluating their patients. The life chart turns out to be 
a very effective way of eliciting a clinical history. There seems to be 
association between life events and episodes of illness. 
The next step in the evolving field of life events was developed by the 
fruitful collaboration of Thomas Holmes and Richard Rahe. They felt that 
commonly encountered stressors would be more useful than taking an 
unstructured history. The underlying assumption is that all life events, be they 
positive or negative, impose a demand for adaptation, and that such demands 
are stressful. 
  Another characteristic of the Holmes-Rahe approach is that the items are 
weighted in terms of their adaptational demand. It is not that the high-scoring 
individual is at risk, but rather that the individual with an increase in life stress 
units is at risk for any number of health consequences. 
PHYSIOLOGIC RESPONSES TO STRESSORS 
The body’s reaction to a stressor (be it real, symbolic, or imagined) is to 
initiate a set of responses that seek to diminish the impact of the stressor. A 
stressor disrupts an organism’s equilibrium, and the stress response consists of 
the initiation of physiologic adjustments that seek to react to the stressor, bring 
about an adaptive response and restoring homeostasis.  
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a) Neurotransmitter Responses to Stress 
Stressors of many kinds activate noradrenergic systems in the brain 
(most notably in the locus coeruleus) and cause the release of catecholamines 
from the autonomic nervous system. Prior exposure to chronic stress results in 
enhanced synthesis of brain norepinephrine. Chronic stress may dampen the 
autonomic nervous system response to that particular stress but leave the 
animal more sensitive to the effects of ensuing stressors. 
Stressors also activate serotonergic systems in the brain as evidenced by 
increased serotonin or 5- hydroxyl tryptamine (5-HT) turnover and there may 
be differences in glucocorticoid regulation of serotonin receptor subtypes, 
which may have implications for serotonergic functioning in depression and 
related illness. 
 Stress also has the effect of increasing dopaminergic neurotransmission 
in mesoprefrontal pathway. 
Over the past two decades it has become clear that amino acid and 
peptidergic neurotransmitters are also intricately involved in the stress 
response. Corticotrophin Releasing Hormone (CRH) has been shown to 
modulate stress-responsive systems that involve glutamatergic, dopaminergic, 
and serotonergic systems, among others.  
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b) Endocrine Responses to Stress 
In response to stress, Hypothalamic Pituitary Adrenal (HPA) axis gets 
activated and stimulates the synthesis and releases of glucocorticoids. 
Glucocorticoids themselves have myriad effects within the body, but their 
actions can be summarized in the very short term as promoting energy 
utilization, increasing cardiovascular activity (in the service of the flight-or-
fight response) and inhibiting functions such as growth, reproduction, and 
immunity. The hypothalamic-pituitary-adrenal (HPA) axis is subject to tight 
negative feedback control by its own end-products.  
The stress response can change dramatically depending on the frequency 
and duration of exposure. This highlights the necessity of specifying these 
elements when trying to understand the role of stress in clinical psychiatric 
illness. 
PSYCHONEUROIMMUNOLOGY 
Researchers have come to appreciate that the immune system is also a 
key player in stress physiology. There are numerous bidirectional interactions 
between brain, behavior, and the immune system. Both innate and specific 
immunity is orchestrated by the release of interleukins or cytokines from 
immune cells. However, the immunoregulatory processes cannot be fully 
understood without taking into account the internal and external milieu in 
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which innate and specific immune responses occur and the interactions of the 
brain, autonomic nervous system, and neuroendocrine axis with the immune 
system.  
The CNS and the immune system are linked by two major physiological 
systems, the HPA and the autonomic nervous system composed of sympathetic 
and parasympathetic branches. 
 Autonomic Nervous System 
Sympathetic release of norepinephrine and neuropeptides Y, together 
with receptor binding of these neurotransmitters by immune cells, serves as the 
signal in this hard-wired connection between the brain and the immune system. 
In addition, sympathetic nerves penetrate into the adrenal gland and cause the 
release of epinephrine into the bloodstream, which circulates to immune cells 
as another sympathetic regulatory signal. 
Sympathetic activation can also enhance other aspects of the immune 
response such as the production of antibodies by B cells and the ability of 
macrophages to release cytokines. Additional studies indicate that sympathetic 
activation can also shunt some immune system cells out of circulating blood 
and into lymphoid organs (e.g., spleen), while recruiting other types of immune 
cells into circulation (e.g., natural killer [NK] cells). In general, activation of 
Sympathetic Nervous System reduce the immune system’s ability to destroy 
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pathogens that live inside cells (e.g., viruses) by decreasing innate and cellular 
immune responses, and enhancing or sparing the humoral immune response to 
pathogens that live outside the cells (e.g., bacteria). Together, these 
observations play as cornerstone for understanding fundamental, 
neuroanatomic signaling between autonomic nervous system and immune 
system. 
 Neuroendocrine Axis 
The other way in which the brain can communicate with the immune 
system is via HPA axis. Cortisol exerts influence on the actions of various cells 
involved in an immune response by suppressing the cellular immune response. 
Indeed a synthetic analog of cortisol is often used to suppress excessive 
immune system response. Cortisol can also prompt some immune cells to 
move out from circulating blood into lymphoid organs or peripheral tissues 
such as the skin. The immune cells can produce neuroendocrine peptides like 
endorphin, ACTH. This suggests that the brain, neuroendocrine axis, and 
immune system use the same molecular signals to communicate with one 
another. 
The brain-immune system interactions have a physiological role in the 
regulation of immunity. Indeed, the release of CRH in the brain alters a variety 
of immune processes, including aspects of innate immunity, cellular immunity, 
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and in vivo measures of antibody production. The brain exerts control over 
immune cells in lymphoid tissue just as it controls other visceral organs 
through a complex series of coordinated autonomic and neuroendocrine 
pathways. 
BEHAVIORAL AND PSYCHOLOGICAL INFLUENCES ON 
IMMUNITY 
Psychological responses are expressed in neural activity with resultant 
changes in neuroendocrine and autonomic function. These changes (behaviors 
and emotions) are capable of altering immunity.  
 Acute Stress and Immunity in Humans 
Acute laboratory stressors (e.g., mental arithmetic) produce profound 
and rapid changes in the immune system due to the redistribution of 
immunoregulatory cells from lymphoid organs such as the spleen into the 
vascular space. Such acute stressors elicit decrease in cellular immune 
responses and increase in markers of inflammation (e.g., IL-6), which are 
thought to be mediated by release of sympathetic neurotransmitters and β-
adrenergic receptor activation. Individuals who are elderly or who are 
undergoing chronic stress show exaggerated immune responses to acute stress. 
They take long time to recover from the administration of stress. Finally, 
among depressed patients, acute psychological stress leads to exaggeration of 
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inflammatory signaling pathway, nuclear transcription factor-κB. Depressed 
patients with more severe sleep disturbance may also be at greater risk for 
elevated levels of IL-6 and other proinflammatory markers.  
 Chronic stress, Depression and Immunity 
In contrast to the effects of laboratory stress, chronic or naturalistic 
stressors such as bereavement or caregiving, as well as depression, are 
associated with reliable decrease of cellular and innate immunity, along with 
increase in proinflammatory cytokine activity. This is possibly due to 
downregulation of glucocorticoid receptor signaling. When the stress remits or 
depressive symptoms resolve, a normalization of natural and cellular immune 
function occurs. Importantly, genetic variation in the expression of 
proinflammatory cytokines may play a role, as stress-induced increase of 
plasma-C-reactive protein is reported to occur only in stressed persons who 
have the A allele of TNF-α 308 G/A polymorphism. 
Heterogeneity in the effects of stress and depression on immunity can be 
accounted for by factors such as age, gender, ethnicity, health behaviors (e.g., 
smoking, alcohol consumption) and coping. Depressed patients who have 
comorbidity for alcohol abuse or tobacco smoking show exaggerated declines 
of natural and cellular immune responses. Personal characteristics such as 
coping and personality (e.g., positive affect), which moderate neuroendocrine 
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and sympathetic activity; also contribute to individual differences of immune 
responses to psychological stress.  
Immune activation leads to changes of peripheral physiology and 
behaviors that are similar to a stress response. With peripheral immune 
activation, there is an induction of a pituitary-adrenal response and autonomic 
activity via central release of CRH. Coincident with these physiological 
changes, animals show reductions in activity, exploration of novel objects, 
social interactions, food and water intake, and sexual behaviors, a response 
pattern that has become known as sickness behaviors. 
Human studies have begun to reveal links between peripheral cytokines 
and behavioral changes. Associations between cytokines and sleep have 
recently been extended to measures of daytime fatigue. Large doses of 
cytokines, given as immunotherapy for cancer or hepatitis C, frequently induce 
sickness behaviors and depressive symptoms, which can be attenuated by 
pretreatment with antidepressant medications. 
Cytokine-induced activation of the HPA axis may represent a risk 
marker for depression. Physiological activation of the immune system with the 
release of proinflammatory cytokines leads to increases of depressed mood and 
anxiety and decreases of memory functions. Administration of the TNF 
antagonist (e.g., Etanercept), which blocks endogenous levels of 
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proinflammatory cytokines, has been found to correlate with improvements in 
depressive symptom severity among 618 psoriasis patients. 
PSYCHOCUTANEOUS DISORDERS 
Classification 
Although there is no single universally accepted classification system of 
psychocutaneous disorders, the one most widely accepted was devised by John 
Koo and Chai Sue Lee. It includes five different groupings, which also 
includes the text revised fourth edition of Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV-TR) classification of psychocutaneous disorders.  
• Psychophysiological disorders are bona fide skin disorders exacerbated 
by stress (e.g.) Psoriasis, eczema 
• Primary psychiatric disorders refer to cases without “real” skin 
disease, but where patients present with serious psychopathology and 
visible skin lesions that are self-induced (e.g.) Trichotillomania, 
delusional parasitosis, psychogenic excoriations etc. 
• Secondary psychiatric disorders refer to cases in which patients 
develop psychological problems as a result of skin disease and 
associated disfigurement (e.g.) Vitiligo. 
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• Cutaneous sensory disorders refers to cases in which patients have 
unpleasant sensations on the skin, such as itching, stinging, burning, or 
crawling, with no proven skin based etiology and for whom a psychiatric 
diagnosis may or may not be evident. These are considered to be 
equivalents of chronic pain syndromes.  
• Koo and Lee’s classification also includes a separate category to 
describe the use of psychotropic medications in treating certain skin 
conditions, which may be more efficacious than traditional 
dermatological treatments. 
Psychosocial stress and coping in skin disorders 
Most patients are able to make appropriate adjustment to their skin 
disorder and do not encounter undue distress. However, some patients with 
chronic skin illness and appearance-altering conditions run the risk of social, 
psychological, and physical distress. The patient’s experience of psychosocial 
distress is variable and depends on  
• The characteristics of skin disorder itself 
• The individual characteristics of patients and his or her life situations 
• Cultural attitudes related to skin disease (often expressed as stigma) 
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Characteristics of the Dermatological Disorder 
The emotional reaction to a particular skin condition is variably affected 
by the patient’s understanding of its origin. In genetically predisposed 
conditions like atopic dermatitis and psoriasis, the patient’s response may 
include blaming parents, as well as feeling unfortunate, frustrated, or helpless. 
The external appearance of skin lesions can lead to different degrees of 
disfigurement. Associated symptoms of persistent intolerable itching, burning, 
or pain may add to psychological distress, insomnia, anxiety, and depression. 
The location of skin lesions might affect the patient’s self-consciousness. 
Lesions directly visible on the face and hands usually cause the greatest 
concern. The age of onset can effect psychological development especially in 
children. In adolescents, chronic skin conditions can be a significant blow to 
self-esteem and image, affecting the maturation of self, sexual identity, and 
personality. The course of the skin illness, with a chronic relapsing condition 
and treatment-related side effects, also has a major bearing on patients and 
their families on a day-to-day basis. 
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Figure-1 
 
 
 
 
 
 
 
 
 
 
 
Figure-1 shows psychosocial factors implicated in origin and maintenance of 
skin- specific affect/distress and systemic adaptation response   
Individual Characteristics 
Age and sex are important when considering a person’s ability to cope 
with a chronic illness. A young woman suffering from psoriasis is likely to be 
far more troubled emotionally than an older man with a similar condition. 
Personality influences a patient’s reaction towards illness, subjective 
experience and coping. The presence of an Axis I psychiatric disorder such as 
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(Genetic factors, early child-mother relationship, 
attachment styles, and cultural stereotypes)
Socio-cultural factors 
Social support Vs rejection 
Cultural stigma, past experience of 
social rejection, relationships & 
social network
Immune 
Response
Skin disease 
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onset, cosmetic disfigurement, 
disease course & treatment factors 
HPA axis & ANS 
Coping strategies 
Adaptation VS 
Disease 
CORTEX-LIMBIC System 
Individual factors: 
Axis disorders, personality traits, 
self-esteem, body image, core 
beliefs and cognitive factors 
Distress/feelings 
Related to the skin condition 
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depression, obsessive-compulsive disorder (OCD), or psychosis can influence 
the patient’s cognition, thoughts, and beliefs about the skin lesions. Depression 
may increase the sensation of itching in pruritic skin disorder such as atopic 
dermatitis, psoriasis, and chronic idiopathic urticaria. 
PSYCHONEUROIMMUNOLOGY OF SKIN DISEASES 
The use of the term psychoneuroimmunology has gained increasing 
attention since R. Adler and N. Cohen demonstrated behaviorally conditioned 
immunosuppression. Most of the data suggesting an association between 
psychosocial stresses and exacerbation of dermatological conditions is derived 
from anecdotal evidence, case series or studies without rigorous standards. 
A.Picardi and D. Abeni reviewed much of the literature with scientific rigor 
and found that evidence for the role of stress in exacerbation of psoriasis, 
atopic dermatitis, urticaria, and alopecia areata was reliable. The field of 
psychoneuroimmunology intends to validate the “psychosomatic” link in 
cutaneous disorders by understanding the potential pathophysiological 
mechanisms underlying the role of stress in the exacerbation of skin diseases. 
Primary sensory stimuli are integrated with corticolimbic input and 
produce an active recognition at cognitive and subconscious levels. The stress 
response is determined by the individual’s interpretation of stimuli as 
distressful and not by the nature of stimuli itself. 
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Immunomodulation 
These neuroendocrine and autonomic changes have profound effects on 
immune regulation by modulatory effects of glucocorticoids, catecholamines, 
and neuropeptides.  
The modulation of the immune system during distress periods may 
largely depend on the chronicity and quality of stress. Chronic stress tends to 
induce an immunosuppressive effect, and acute stress leads to immune 
enhancement with immediate survival mechanisms. 
PSORIASIS 
The writer John Updike, who had psoriasis himself, so poignantly said 
about being a person with psoriasis  “I am silvery, scaly. Puddles of flakes 
form wherever I rest my flesh. Lusty, though we are loathsome to love. Keen-
sighted, though we hate to look upon ourselves. The name of disease, 
spiritually speaking, is Humiliation”. 
Epidemiology and Clinical Features 
Psoriasis is a chronic, relapsing skin disease presenting with 
erythematous, scaling papules, and indurated plaques involving the vasculature 
as well as the epidermis, arising preferentially on the elbows, knees, and scalp. 
The clinical presentation takes various forms, some causing nail dystrophies 
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and arthritis. The morphology of the skin lesion varies from pinpoint plaques 
to extensive lesions covered with silvery scales or pustular formations.  
It affects males and females equally. Psoriasis is hereditary with an age 
of onset mostly in the early 20s. It affects 1.5%– 2% of the population in 
western countries. Childhood onset predicts a severe and chronic course and is 
usually associated with a positive family history. Early onset psoriasis has been 
associated with greater difficulties with expression of anger, a personality trait 
that may add to a patient’s vulnerability to stress and depression. For most 
patients, it is a life-long condition with unpredictable relapses (Christophers & 
Mrowietz 1999; Habif 2004). 
 The pathogenesis of psoriasis is incompletely understood. Genetic, 
immunological and environmental factors affect its development and prognosis 
(Christophers & Mrowietz 1999; Habif 2004). Common trigger factors include 
physical trauma (Koebner’s phenomenon: rubbing and scratching stimulate the 
psoriatic proliferative process), acute bacterial or viral infections and drugs. 
Psoriasis can be induced by β-adrenergic blockers and lithium amongst other 
medications. Lithium induced psoriasis resolves with its discontinuation 
(Krahn and Goldberg, 1994).  
Alcohol ingestion is also a known trigger. A controlled study of Finnish 
men elicited retrospective data about alcohol intake prior to onset as well as 
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before the current skin examination, showing that psoriasis patients reported 
greater alcohol consumption during both periods compared with men with 
other skin diseases, Psoriasis patients, unlike controls, did not decrease their 
intake after diseases onset, perhaps because of their emotional distress 
(Poikolainen, 1990). 
Stressful life events are associated with higher levels of Substance P 
(SP) in the central and peripheral nervous systems of animal models. There is 
evidence for higher Nerve Growth Factor (NGF) levels in response to stress, 
which plays a central role in regulating skin innervations and upregulating 
Neuropeptides (NPs). Several studies indicate that increased expression of 
NGF in keratinocytes may be an early event in the pathogenesis of psoriasis. 
NGF stimulates T-lymphocyte proliferation and mast cell degranulation. 
Psychiatric morbidity 
The connection between psychological factors and psoriasis is largely 
unexplained. It is not due only to altered neuropeptides in the skin (Pincelli et 
al. 1994), although stress does increase the neuropeptides content of lesions, 
with a concomitant decrease in enzymes that degrade neuropeptides, especially 
mast cell chymase (Harvima et al. 1993). In addition, the concentration in the 
blood of certain neuromediators, especially β-endorphin, changes during 
exacerbations (Misery 1997). 
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 Psychiatric morbidity has been shown to be highly prevalent in 
dermatology patients with an overall prevalence of 40.2%. Self report 
measures were used for correlation between psychiatric and dermatological 
morbidity and it was found that 75% of these cases were caused by or closely 
related to skin diseases (Wessely 1989).  
 Patients with psoriasis have been reported to have a high prevalence of 
Generalized Anxiety Disorder and Major Depressive Disorder (anxiety, 
depression) and Comorbid Personality Disorders. A variety of 
psychopathological disorders appear to be increased in patients with psoriasis 
(Fried et al. 1995; Gupta & Gupta 1998). Depression and obsessionality as 
well as alcoholism are common findings (Koblenzer 1999).  
 Depression has been shown to be associated with psoriasis. This was 
significantly higher among inpatients with Psoriasis as compared to Atopic 
eczema, Acne, Alopecia and outpatients with Psoriasis (Gupta, 1998). Akay 
(2002) while comparing depression scores using Becks Depression Inventory 
among Psoriasis, Lichen planus and normal controls found that depression 
scores were found to be higher in psoriasis (58%) when compared to others 
(53% & 20%). 
Hughes et al (1983) found that 33% of dermatology inpatients and 15% 
of outpatients had high scores on a standard measure of depression. Further 
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exploration showed that the symptoms were caused by inconvenience, 
disfigurement and stigma attached to the disease. 
 Devrimci – ozugren (2000) also found that patients with psoriasis 
reported significantly higher degrees of depression and more body cathexis 
problems than controls. In addition the risk for developing psoriasis increased 
significantly in patients with moderate and severe depression. 
Fried (1995) found that approximately half of the patients were found to 
have moderate to extreme levels of anxiety, depression and anger both during 
their flare up of disease and during periods of remission. Patients were also 
found to have pruritus associated with their flares. Psychologic morbidity was 
positively associated with length of disease flare.  
Pruritus is a common symptom in patients with Psoriasis. In Psoriasis, 
the severity of pruritus is associated with higher depression scores and a 
greater risk for suicide. An improvement in pruritus led to a decrease in 
depression scores.   
Anxiety and Stress in Psoriasis 
Anxiety is a common reaction to the stress of having a physical illness. 
It can be pervasive and persistent, mixed with depression and anger, and out of 
proportion to the condition causing it. The ‘fear of being negatively evaluated’ 
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contributes greatly to the anxiety of patients with Psoriasis, particularly of 
those with severe disease (Leary et al. 1998). 
Many patients are sure that stress triggered their Psoriasis originally and 
still exacerbates it (Savin 1970). Most publications on the subject support the 
existence of this association. Yet an aura of doubt lingers on for a variety of 
reasons. 
There is conflicting literature regarding the role of psychosocial stressors 
in psoriasis. In some patients stress appears to play an important part in the 
clinical course of this condition. It has been suggested that upsetting life events 
precede the onset of psoriasis in up to 70% of the cases and relapses in up to 
90% (Picardi & Abeni 2001). However, Majority of the studies that have 
examined this association has been uncontrolled or has had methodological 
problems. Nevertheless, they provide anecdotal evidence of an association 
between stress and psoriasis (Picardi & Abeni 2001). Family upsets are the 
most commonly related events, followed by work or school pressures, and 
financial worries. 
Psoriasis itself acts as a stressor and influences the social and 
physiological well being of the patients. Stressful life events have been 
considered possible etiological factors influencing the onset of psoriasis 
(Zachariae et al, 2004, Jowett, 1983, Ginsburg, 1989). It has also been 
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suggested that periods with increased disease activity may be preceded by 
increased distress (Picardi, 2001). 
Farber et al (1968, 1974) using a questionnaire survey with initial 2144 
patients with psoriasis and then with 5600 patients found that approximately 
33% stated that new patches of psoriasis appeared at times of worry, 33% said 
they didn’t and the remaining were uncertain. 
Several studies by Farber’s group attempt to elucidate a pathway 
between stress and psoriasis via substance P (Farber 1990, 1991). They suggest 
that an underlying mechanism is neurogenic inflammation, induced by 
exogenous or endogenous stimuli, mediated by neuropeptides. Farber et al 
speculates descending autonomic fibers may trigger antidromatic release of 
neuropeptides in the skin. Local release of neuropeptides from sensory nerves 
in the skin in response to stressful stimuli, however, has not been 
demonstrated, although substance P and vasoactive intestinal peptide (VIP) 
were significantly elevated in psoriatic lesions compared with non lesional skin 
and normal control skin. 
There is a potential link between neural factors such as substance P and 
others, mast cell proinflammatory mediators, and cellular inflammatory 
response as having significance in the stress related exacerbation of many 
dermatosis. 
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Treatment 
The prevalence of psychiatric comorbidity and emerging evidence for 
stress-induced exacerbations of psoriasis has led to the development of 
psychosocial intervention as an important adjunctive therapy in the 
management of psoriasis.  
Fortune et al (2003) assessed clinical severity of psoriasis, psychological 
distress and other potential confounders of treatment outcome such as skin 
prototype, family history of psoriasis and alcohol intake before starting PUVA 
therapy. They found that psychological distress in the form of excessive 
worrying has a significant and detrimental effect on treatment outcome in 
patients with psoriasis. Patients with psoriasis who are classified as high- level 
worriers may benefit from adjunctive psychological intervention before and 
during treatment. 
The psychotherapeutic modalities with evidence for significant clinical 
improvement include Hypnosis, Meditation, Cognitive Behavioral Therapy, 
and Guided Imagery Training. Scharloo et al (2000) showed that emotional 
expression, active coping and seeking social support were associated with 
improved mental and physical health one year later. This indicates that 
psychological intervention techniques like Hypnotherapy, Imagery, Relaxation 
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and Stress management techniques have thus been reported to help patients 
suffering from psoriasis.  
 There are limited data on controlled trails of psychopharmacological 
treatments of anxiety and depression in psoriasis patients and its effect on the 
course of psoriasis.    
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MATERIALS AND METHODS 
This is a cross sectional study conducted from May 2010 to August 2010 
in the Department of Dermatology, Raja Mirasudhar Hospital, Thanjavur 
Medical College, Thanjavur. This tertiary care hospital caters the rural 
population of nearly seven districts. The department of Dermatology runs an 
outpatient clinic for psoriasis every Tuesday and Friday with an attendance of 
200 patients per week. All the cases were screened and diagnosed by a 
consultant dermatologist. 
Inclusion criteria  
1. Age more than 15 years 
2. Patients diagnosed as psoriasis and undergoing treatment in Government 
Raja Mirasudhar Hospital, Thanjavur. 
3. Patients with no history of psychiatric illness before the onset of disease. 
Exclusion criteria 
1. Patients with other chronic diseases like vitiligo. 
2. Patients with history of psychiatric illness before the onset of disease. 
3. Patients who were having chronic systemic illness like Diabetes 
mellitus, and Hypertension which may lead onto Depression. 
4. Patients who were on systemic steroids as part of their treatment. 
5. Those were not willing and uncooperative for the study. 
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Tools used 
1. Semi structured interview to assess the socio demographic data. 
2. ICD-10 (International classification of mental and behavioral disorders-
clinical descriptions and diagnostic guidelines, 10th revision, 1992) to 
assess psychiatric disorders. 
3. Hamilton Depression Rating Scale (HAM-D) 
4. Presumptive Stressful Life Events Scale (Gurmeet Singh et al 1984) 
5. Modified Kuppuswami scale for Socio Economic Status (SES) 
Forty five consecutive cases were selected from the Psoriasis clinic and 
dermatology ward. Initial screening was done to rule out systemic diseases and 
any history of drug treatment with systemic steroids.  
A consultant dermatologist has screened the patients for psoriasis and 
the diagnosis was confirmed by him. 
A proforma consisting socio-demographic and clinical details was 
completed. These included items such as name, age, sex, hospital no, 
education, occupation, family income per month, marital status, type of family, 
history of substance use pattern, family history of mental illness, family history 
of psoriasis, clinical information regarding symptoms and current 
management. (Appendix-I) 
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A clinical interview was conducted to evaluate psychiatric morbidity and 
the diagnosis was made using ICD-10.  
Hamilton Depression Rating Scale was also administered to assess 
depression in these patients. 
Presumptive Stressful Life Events Scale (Gurmeet Singh) was 
administered to all patients and life events which have occurred during their 
life time and past one year were recorded with the exact time of occurrence. 
Modified Kuppuswamy scale was used to classify socio economic 
status. 
The questions were read aloud to the patients in their mother tongue and 
were asked to respond. 
• International classification of mental and behavioral disorders 
(ICD-10, 1992): first developed by WHO. The tenth revision of ICD-
10(1992) based on Clinical descriptions and diagnostic guidelines are 
commonly used. The chapter V deals with mental and behavioral 
disorder. Alphanumerical coding scheme, based on codes with a single 
letter followed by two numbers at three character level is used. 
• Hamilton Depression Rating Scale (HAM-D, 17 item scale): First 
introduced by Max Hamilton in 1960, it has since become the most 
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widely used and accepted outcome measure for evaluating depression 
severity. The Hamilton Depression Rating Scale is a 17-item scale that 
evaluates depressed mood, vegetative and cognitive symptoms of 
depression, and co-morbid anxiety symptoms. It provides ratings on 
current DSM-IV symptoms of depression, with the exceptions of 
hypersomnia, increased appetite, and concentration/indecision.  
The 17-items are rated on either a 5-point (0-4) or a 3-point (0-2) 
scale. In general, the 5-point scale items use a rating of 0 = absent; 1 = 
doubtful to mild; 2 = mild to moderate; 3 = moderate to severe; 4 = very 
severe. A rating of 4 is usually reserved for extreme symptoms. The 3-
point scale items used a rating of 0 = absent; 1 = probable or mild; 2 = 
definite. The HAM-D was one of the first rating scales developed to 
quantify the severity of depressive symptomatology. Interpretation of the 
total scores: very severe, >23; severe, 19-22; moderate, 14-18; mild, 8-
13; and no depression, 0-7. The questionnaire is presently one of the 
most commonly used scales for rating depression in medical research. 
(Appendix-II) 
• Presumptive Stressful Life Events Scale developed by Gurmeet Singh 
et al has 51 items which is based on the consensus a priori method and 
can be adapted to assess the events in lifetime or within a short span of 
 
34 
 
time (1-6 months). Singh developed this scale suitable for assessing 
stressful life events for Indian patients in 1981 by using open-ended 
questionnaire on a sample of 200 adult subjects. It was based on fruitful 
collaborations of Holmes and Rahe, who believed that some kind of a 
list of commonly encountered stressors would be more useful than the 
relatively unregulated process of taking an unstructured history. After 
considerable research, they developed a list of 51 life events relevant to 
Indian conditions, ranging in severity from death of a spouse to going on 
a pleasure trip/pilgrimage. Scale items are classified into desirable, 
undesirable, or ambiguous; and personal or impersonal. A cumulative 
score can be obtained by summing up the individual scores weighed 
depending upon the stress caused to the individual. (Appendix-III) 
• Modified Kuppuswamy scale for Socio Economic Status (SES) 
Kuppuswamy scale is widely used to measure the socio-economic status 
of an individual in urban community based on three variables namely 
Education, Occupation and Income. The three variables are clearly 
defined and appropriate scores maintained. Each variable consist of 
seven categories. According to the total scores obtained in the three 
variables, the Socio Economic Status are grouped into five classes viz 
upper, upper middle, lower middle, upper lower and lower. In the 
present study, Modified Kuppuswamy’s SES Scale (updated by 
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N.Kumar, C.Shekhar, 2007) was used. The authors revised family 
income per month according to the modification of price index for 2007. 
(Appendix-IV) 
Approval was obtained from the Ethical committee of Thanjavur 
medical college.  
Informed consent was obtained from the patients before participating in 
the study.  
Statistical analysis 
Descriptive statistics were computed. Categorical variables were 
described as frequencies and percentages. The chi-square test was used to 
compare categorical variables. Comparison of continuous variables was 
analyzed with independent sample test. A “p value” of less than 0.05 was 
considered clinically significant.  
Data was managed and analyzed using the statistical package for social 
sciences (SPSS) software version 12.0.  
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RESULTS 
Table-1 
Table showing Socio demographic variables among patients with Psoriasis. 
 
Socio demographic variables Psoriasis patients (N=45) 
n % 
Age (in years) 
a) 18-44  
b) 45-64 
c) More than 64 
 
16 
23 
6 
 
35.6 
51.1 
13.3 
Sex 
a) Male 
b) Female 
 
35 
10 
 
77.8 
22.2 
Marital status 
a) Single 
b) Married 
c) Widowed 
d) Separated 
e) Divorced 
 
0 
44 
0 
1 
0 
 
0 
97.8 
0 
2.2 
0 
Religion 
a) Hindu 
b) Muslim 
c) Christian 
d) Others 
 
44 
1 
0 
0 
 
97.8 
2.2 
0 
0 
Socio Economic Status 
a) Upper  
b) Upper middle 
c) Lower middle 
d) Upper lower 
e) Lower 
 
0 
0 
18 
27 
0 
 
0 
0 
40.0 
60.0 
0 
Type of family 
a) Nuclear 
b) Joint 
c) Extended 
d) Broken 
 
36 
5 
0 
4 
 
80.0 
11.1 
0 
8.9 
  Mean age = 50.1; Median age = 50 
  
belo
Figu
Figure 
Figure-2 
ng to 18-4
Figur
re-3 resul
showing v
results sh
4 years an
e showing
ts show 35
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
arious age
ow major
d the rem
 sex distrib
 were mal
18‐44 yrs
 
37 
Figure-2
 groups am
ity belong
aining 13.3
Figure-3
ution amo
es (77.8%
45‐64 yr
Age
Gender
ong patie
 to 45-64
% belong
ng patien
) and 10 w
s > 64
nts with P
 years (5
 to more th
ts with Pso
ere female
 yrs
Male
Female
soriasis 
 
1.1%), 35
an 64 yea
riasis  
 
s (22.2%)
.6% 
rs. 
.  
 
38 
 
Table-1 
 A total of 45 patients suffering from Psoriasis were evaluated for the 
study. Age of the patients ranged from 29 to 67 years with the Mean age of 
50.1 years and the Median age of 50 years. Among 45 patients, 35 were male 
(77.8%) and 10 were female (22.2%). Majority (97.8%) belong to Hindu and 
2.2% belong to Muslim. 13.3% of the patients educated up to high school / 
post high school, 35.6% up to middle school, 46.7% up to primary school and 
4.4% were illiterate. 13.3% were skilled workers, 40% were agricultural/ 
clerical and the majority (46.6%) was semi skilled/Unskilled workers. Majority 
of them (60%) belong to upper lower Socio economic status and the remaining 
40% lower middle. Majorities (97.8%) were married and only one patient 
(2.2%) was separated. Majorities (80%) were living in a nuclear family, 11.1% 
were living in a joint family and 8.9% belong to broken family.  
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Psychiatric morbidity 
Table-3 
Table showing comparison of Socio demographic variable and Psychiatric 
morbidity among patients with Psoriasis 
 
Socio demographic 
variables 
Patients with 
CPD 
Patients 
without CPD Results 
n % n % 
Age in 
years 
18 – 44 
45 – 64 
Above 65 
9  
16  
5 
30.0 
53.3 
16.7 
7 
7 
1 
46.7 
46.7 
6.7 
df = 2 
x2 = 1.618 
p = 0.445 
p > 0.05 NS 
Sex Male Female 
26 
4 
86.7 
13.3 
9 
6 
60.0 
40.0 
df = 1 
x2 = 4.114 
p = 0.043 
p < 0.05  
Significant 
Religion Hindu Muslim 
30 
0 
100.0 
0 
14 
1 
93.3 
6.7 
df = 1 
x2 = 2.045 
p = 0.153 
p > 0.05 NS 
Socio 
Economic 
Status 
Lower middle 
Upper lower 
12 
18 
40.0 
60.0 
6 
9  
40.0 
60.0 
df = 1 
x2 = 0.000 
p = 1.000 
p > 0.05 NS 
Marital 
Status 
Married 
Separated 
29 
1 
96.7 
3.3 
15 
0 
100.0 
0 
df = 1 
x2 = 0.511 
p = 0.475 
p > 0.05 NS 
Marital life 
Cordial 
Satisfactory 
Unsatisfactory 
Strained 
8 
17 
2 
3 
26.7 
56.7 
6.7 
10.0 
4 
9 
2 
0 
26.7 
60.0 
13.3 
0 
df = 3 
x2 = 2.019 
p = 0.568 
p > 0.05 NS 
Type of 
family 
Nuclear 
Joint 
Broken 
22 
4 
4 
73.3 
13.3 
13.3 
14 
1 
0 
93.3 
6.7 
0 
df = 2 
x2 = 2.900 
p = 0.235 
p > 0.05 NS 
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Table-5 
Table showing comparison of age of onset of Psoriasis and psychiatric 
morbidity among patients with Psoriasis 
 
Age of onset of 
psoriasis (years) 
Patients 
with CPD 
Patients 
without CPD Results 
n % n % 
Below 31 yrs 7 23.3 1 6.7 
df = 2 
x2 = 4.622 
p = 0.099 
p > 0.05 NS 
32-51 yrs 14 46.7 12 80.0 
52 & above 9 30.0 2 13.3 
 
Age of onset of Psoriasis ranged from 28 to 68 years with mean age of 
42.87years. Table-5 results show no statistical significance made out between 
the age of onset of Psoriasis and psychiatric morbidity among patients with 
Psoriasis. In this study patients with age of onset of Psoriasis from 32 to 51 
years had higher psychiatric morbidity (46.7%).  
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Table-6 
Table showing comparison of duration of Psoriasis and psychiatric morbidity 
among patients with Psoriasis 
Duration of 
Psoriasis (years) 
Patients 
with CPD 
Patients 
without CPD Results 
n % n % 
Below 3 yrs 4 13.3 4 26.7 df = 2 
x2= 3.617 
p = 0.164 
p > 0.05 NS 
4-10 yrs 17 56.7 10 66.7 
11 & above 9 30.0 1 6.7 
 
The duration of illness ranged from 1 to 30 years with mean duration of 
7.56 years.Table-6 results show no statistical significance found between 
duration of Psoriasis and psychiatric morbidity among patients with Psoriasis. 
In this study, patients with duration of Psoriasis for 4 to 10 years had higher 
psychiatric morbidity (56.7%).  
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Table-7 
Table showing comparison of pruritus was aggravated by stress and HAM-D 
among patients with Psoriasis 
 
Pruritus-
aggravated by 
stress 
Normal  Depressed 
Results 
n % n % 
Yes 20 83.3 14 87.5 df = 1 
x2= 0.131 
p = 0.718 
p > 0.05 NS No 4 16.7 2 12.5 
 
Table-7 results show no statistical significance made out between 
patients who reported that stress increased their pruritus and HAM-D 
(Hamilton Depression Rating Scale) scores among patients with Psoriasis. 
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Table-8 
Table showing comparison of socio demographic variable and total number of 
stressful life events in the past 1 year among patients with Psoriasis [N=37] 
 
Socio Demographic 
Variables 
Total number of 
life events < 2 
Total number 
of life events ≥ 2 Results 
n % n % 
Age in 
years 
18 – 44 
45 – 64 
Above 65 
11 
13 
5 
37.9 
44.8 
17.2 
1 
7 
0 
12.5 
87.5 
0 
df = 2 
x2 = 4.742 
p = 0.093 
p > 0.05 NS 
Sex Male Female 
22 
7 
75.9 
24.1 
6 
2 
75.0 
25.0 
df = 1 
x2 = 0.003 
p = 0.960 
p > 0.05 NS 
Religion Hindu Muslim 
28 
1 
96.6 
3.4 
8 
0 
100.0 
0 
df = 1 
x2 = 0.284 
p = 0.594 
p > 0.05 NS 
Socio 
Economic 
Status 
Lower middle 
Upper lower 
11 
18 
37.9 
62.1 
1 
7 
12.5 
87.5 
df = 1 
x2 = 1.851 
p = 0.174 
p > 0.05 NS 
Marital 
Status 
Married 
Separated 
28 
1 
96.6 
3.4 
8 
0 
100.0 
0 
df = 1 
x2 = 0.284 
p = 0.594 
p > 0.05 NS 
Marital 
life 
Cordial 
Satisfactory 
Unsatisfactory 
Strained 
6 
18 
3 
2 
20.7 
62.1 
10.3 
6.9 
3 
4 
1 
0 
37.5 
50.0 
12.5 
0 
df = 3 
x2 = 1.461 
p = 0.691 
p > 0.05 NS 
Type of 
family 
Nuclear 
Joint 
Broken 
21 
5 
3 
72.4 
17.2 
10.3 
8 
0 
0 
100.0 
0 
0 
df = 2 
x2 = 2.816 
p = 0.245 
p > 0.05 NS 
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In this study, total of 37 patients (82.2%) had stressful life events and 
there is no statistical significance found between Socio demographic variable 
and total number of stressful life events in the past 1 year among patients with 
Psoriasis. (Table-8)  
In the total sample, the number of stressful life events during their life 
time ranges from 2 to 10 with the Mean of 5.15 with SD of 1.74. In the past 
one year, it ranges from 0 to 4 with the Mean of 1.66 with SD of 1.06.  
In the same way, cumulative life events score during their life time 
ranges from 100 to 449 with the Mean stress score of 244.04, SD of 84.76. In 
the past one year, it ranges from 0 to 191 with the Mean of 87.55, SD of 54.19.  
In this study, patients in the age group 45 to 64 years had higher risk to 2 
or more number of stressful life events compared to other groups. Male 
patients had higher risk to stressful life events compared to females. Patients 
belonging to upper lower Socio Economic Status and nuclear families were at 
more risk of exposure to high number of life events than others. 
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Table-10 
Table showing comparison of socio demographic variables and cumulative life 
event score in past one year among patients with Psoriasis (N=37) 
Socio Demographic 
Variables 
Cumulative life event score 
Results Below 68 69 - 140 141 & above 
n % n % n % 
Age in years 
18 – 44 
45 – 64 
Above 65  
4 
4 
1 
44.4 
44.4 
11.1 
5 
10 
4 
26.3 
52.6 
21.1 
3 
6 
0 
33.3 
66.7 
0 
df = 4 
x2 = 3.101 
p = 0.541 
p > 0.05 NS 
Sex Male  Female 
5 
4 
55.6 
44.4 
17 
2 
89.5 
10.5 
6 
3 
66.7 
33.3 
df = 2 
x2 = 4.341 
p = 0.114 
p > 0.05 NS 
Religion Hindu Muslim 
8 
1 
88.9 
11.1 
19 
0 
100.0
0 
9 
0 
100.0 
0 
df = 2 
x2 = 3.198 
p = 0.202 
p > 0.05 NS 
Socio 
Economic 
Status 
Lower middle 
Upper lower 
2 
7 
22.2 
77.8 
9 
10 
47.4 
52.6 
1 
8 
11.1 
88.9 
df = 2 
x2 = 4.229 
p = 0.121 
p > 0.05 NS 
Marital 
Status 
Married  
Separated 
8 
1 
88.9 
11.1 
19 
0 
100.0
0 
9 
0 
100.0 
0 
df = 2 
x2 = 3.198 
p = 0.202 
p > 0.05 NS 
Marital life 
Cordial 
Satisfactory 
Unsatisfactory 
Strained 
1 
6 
0 
2 
11.1 
66.7 
0 
22.2 
5 
12 
2 
0 
26.3 
63.2 
10.5 
0 
3 
4 
2 
0 
33.3 
44.4 
22.2 
0 
df = 6 
x2 = 9.722 
p = 0.137 
p > 0.05 NS 
Type of 
family 
Nuclear 
Joint 
Broken 
5 
2 
2 
55.6 
22.2 
22.2 
16 
3 
0 
84.2 
15.8 
0 
8 
0 
1 
88.9 
0 
11.1 
df = 4 
x2 = 6.453 
p = 0.168 
p > 0.05 NS 
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Table-11 
Table showing comparison of cumulative life events score in the past one year 
and psychiatric morbidity among patients with Psoriasis 
Cumulative life 
events score in 
past one year 
Patients with 
CPD 
Patients 
without CPD Results 
n % n % 
Below 68 6 22.2 3 30.0 df = 2 
x2 = 2.782 
p = 0.249 
p > 0.05 NS 
69-140 16 59.3 3 30.0 
141 & above 5 18.5 4 40.0 
 
Table-11 results show no statistical significance between cumulative life 
events score in the past one year and Psoriatic patients with or without 
psychiatric morbidity. 
Table-12 
Table showing comparison of total no of life events in past one year and 
psychiatric morbidity 
 
Table-12 results show no statistical significance between total number of 
life events in the past one year and Psoriatic patients with or without 
psychiatric morbidity. 
Total no of 
life events in 
past 1 year 
Patients with 
CPD 
Patients without 
CPD Results 
n % n % 
Below 2 23 85.2 6 60.0 
df = 1 
x2 = 2.731 
p = 0.098 
p > 0.05 NS 2 & Above 4 14.8 4 40.0 
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Table-13 
Table showing correlation of mean stressful life events score in past one year 
and psychiatric morbidity among patients with Psoriasis 
 
Variable Patients with CPD (n=30) 
Patients without 
CPD (n=15) Result 
Mean no of 
stressful life events 
in past one year 
1.73±0.828 1.53±1.457 
t=0.589 
df=43 
p=0.559 
p>0.05 NS 
Mean cumulative 
life event score in 
past one year 
91.67±44.643 79.33±70.661 
t=0.716 
df=43 
P=0.478 
p>0.05 NS 
 
Table-13 results show no statistical significance between Mean number of 
stressful life events or cumulative score among Psoriatic patients with or 
without psychiatric morbidity. 
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DISCUSSION 
The aim of the study is to know the prevalence of psychiatric morbidity 
and stressful life events among patients with psoriasis; to correlate them with 
socio demographic variables and to know their clinical relevance. The study 
was done in the native population who were attending dermatology department 
at Government Raja Mirasudhar hospital, Thanjavur. A homogenous 
population was chosen on the basis of inclusion criteria. Forty five patients 
seen consecutively were chosen.  
This study (Table-1) showed male preponderance over females (males 
77.8% Vs females 22.2% a male female ratio of 3.5:1) which is almost similar 
to the finding of Kaur, 1997 (67% males, M:F ratio of 2.03:1), Okhandiar, 
1963 (M:F ratio of 2.46:1), Bedi T R, 1977 (M:F ratio of 2.5:1). This study 
does not have concurrence regarding sex distribution with Manolache L, 2010 
(females 66%). 
In this study, the age of the patients ranged from 29-67 years with the 
mean age of 50 years and the median age of 50 years. This is similar to 
findings observed by Manolache L, 2010 (Median age 50 years). Age and 
Mean age in our study is not similar to the study done by Cemal Bilac, 2009. 
In his study, age ranges from 16 to 81and the mean age was 39.5±15.  
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Henseler and Christopher, on the basis of phenotype database of 2147 
patients recognized two distinct patient cohorts. One cohort had early onset 
(Type I) of Psoriasis in the second decade and other cohort had late onset 
(Type II) of the disease in the fifth decade. 
In this study, highest incidence is noted in the age group of 45-64 years. 
This is contrary to the study done by Okhandiar, 1963 (the highest incidence is 
in the age group of 20-30 years). 
In this study, the mean age of onset of psoriasis in males and females is 
found to be 44.7 and 36.4 years respectively. These results are similar to the 
studies done by Bedi, 1977. In his study, he observed that females had lower 
mean age of onset compared to males. These findings are not in agreement 
with Kaur, 1997. He found that women had slightly lower mean age of onset 
(27.6 years) compared to men (30.9 years).  
In this study, the duration of illness ranged from 1-30 years with mean 
duration of 7.55 years. This finding is not in agreement with the study done by 
Cemal Bilac, 2009, who observed the duration of disease ranged between 1 
month and 40 months with the mean of 12.4±9.9 months.  
There are only few studies which have made record of family history of 
psoriasis in their patients.  
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Indian studies report lower familial incidence of the disease. In this 
study, about 7 patients (15.6%) gave a family history of psoriasis. This is 
comparable to the study done by Manolache L, 2010 (10.65%), Bedi TR, 1995 
(14%). Our finding is not in agreement with the findings in the study of Farber 
et al 1974 (36%), Kaur et al 1997 (2%).  
Pruritus is the most frequent symptom in patients with Psoriasis 
(96.6%). Prevalence of pruritus in Psoriasis, ranging from 63 to 84%, has been 
reported from different parts of the world. Despite a high prevalence of 
pruritus in psoriasis, limited information is available on this subject. 
In our study, about 40 (88.9%) out of total 45 patients gave history of 
pruritus. This is consistent with the studies of Okhandiar et al 1963 (95%), 
Bedi TR 1977 (81%). Our finding is slightly higher than the study done by 
Kaur et al 1997 (65%). So, the results of various studies suggest that psoriasis 
is definitely pruriginous disorder adding to the morbidity of this dermatosis.  
 Psychiatric morbidity is said to be high in patients with Psoriasis. In our 
study, the psychiatric morbidity is 66.7% (30 out of the total 45 patients). Our 
findings are slightly higher than that observed in the studies of Neelu Sharma, 
2003 (53.3%). Our findings are contrary to the findings by Mattoo et al 2001 
(24.7%), Pulimood S, 1996 (11%).  
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The most common psychiatric diagnoses in Psoriasis are adjustment 
disorder and depression. In our study, among psychiatric morbidity, depressive 
disorder constitutes 24.4%, alcohol harmful use 28.9%, alcohol dependence 
4.4% and depression with comorbid substance abuse 8.9%. This is in 
agreement with the findings in the study of Mattoo, 2001. In his study, he 
found that Depressive episode constitutes 29%, Dysthymia 4% and Adjustment 
disorder 62%. Our findings are slightly higher than that seen in the study done 
by Neelu Sharma, 2003, who observed 23.3% of Psoriatic patients had 
Depression, 3.3% Anxiety. 
Gupta et al in 1998 has explored the relationship of depression to 
pruritus and concluded that degree of depression increased with severity of 
pruritus. In our study, there is no difference between depressed and non 
depressed subjects in perceiving the stress with regard to aggravation of 
pruritus.  
 Psychological factors precipitate, and contribute to, the morbidity of 
many psychosomatic disorders. Psychoneuroimmunologists have noted that 
stressful life events are important psychosocial factors which can affect the 
nervous, endocrine, and immune systems (Farber, 1991). 
 The total number of life events and its score for the preceding one year 
have been analyzed (Table-8 & 10)). It has been found that 21.6% of patients 
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had more than two stressful life events during preceding one year, which is 
considered as significant (Gurmeet Singh, 1984). In our study, 75.7% of 
patients had cumulative life events score more than 69, which is significant. 
An attempt has been made to find the correlation if any between life events and 
psychiatric morbidity. Logically, it seems that the person with more life events 
will have more risk of psychiatric illness and exacerbation of psoriasis. But our 
study showed no statistical significance between number of life events, scoring 
and psychiatric morbidity. (Table-9 & 11) 
 In this study, there is no significance made out between cumulative life 
event score in the past one year and psychiatric morbidity among patients with 
Psoriasis. This finding is contrary to Fava GA, 1980. He reported that the 
patients with Psoriasis and chronic urticaria were exposed to stressful life 
situations before the onset of disease and suffered from psychological distress 
(anxiety, depression, inadequacy) significantly more than those with fungal 
infections.   
 Stressful life events may affect the onset or exacerbation of some skin 
diseases. Estimates of proportion of Psoriasis patients whose disease is affected 
by stressful events vary from 40% to 80% (Gupta MA, 1989) depending on 
how stress is defined (acute or chronic) and measured (by self reports or 
responses on standardized checklists).  
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 In this study, 82.2% of patients (37 out of 45 Psoriatic patients) 
experienced stressful life events within 1 year preceding the exacerbation of 
disease. This is similar to studies done by Polenghi et al, 1987 (79% of the 
Psoriatic patients experienced stressful life events within one year preceding 
the onset of illness).   
 In this study, 71.1% of psoriatic patients experienced at least 1 stressful 
life event within 6 months preceding the onset and exacerbation of disease. 
This is similar to the study, done by Baldero, 1989, who found that 90% of 
patients with Psoriasis reported at least one event within 6 months preceding 
the onset of illness. 
  Polenghi et al, 1989, found that 72% of men and 71% of women with 
Psoriasis reported stressful life events during the year preceding the onset of 
their illness (Psoriasis).  In our study, it is found that 80% (28 out of 35) of 
men and 90% (9 out of 10) of women with Psoriasis reported stressful life 
events during the year preceding the exacerbation of Psoriasis.  
 In this study, in decreasing order of frequency, the most common 
stressful life events observed are financial loss or problems, unemployment of 
self or family member, death of close family member, illness of the family 
member, family conflict, change in residence, marital conflict, excessive 
alcohol or drug use by the family member, major personal illness or injury, 
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change in sleeping habits and miscellaneous. This is similar to the observation 
made by S K Malhotra 2008, who found that in psoriasis vulgaris group, the 
most common stressful life event seen was financial loss or problems, followed 
by death of close family member, sexual problems, family conflict, major 
personal illness or injury, transfer or change in working conditions, failure in 
examinations, family member unemployed, illness of family member, getting 
married or engaged and miscellaneous compared to chronic urticaria group. 
In summary, this study has found 66.7% of patients suffered from 
psychiatric illness. Middle age, male sex, married status, lower socio economic 
status, nuclear family have been important risk factor for psoriasis and 
psychiatric morbidity. Mood disorders (depression) and alcohol harmful 
use/dependence are found to be the common psychiatric diagnoses. Number of 
life events and score in the past one year do not differ significantly in psoriatic 
patients with or without psychiatric morbidity. 
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CONCLUSION 
• Psoriasis is more common in males than females. 
• Psoriasis is more common in middle age and married than unmarried 
individuals. 
• Most of the patients with psoriasis belong to lower socio economic 
status. 
• Psychiatric morbidity is common in patients with Psoriasis. 
• Middle age, male sex, married status, lower socio economic status and 
nuclear family have been important risk factors for psychiatric morbidity 
in psoriasis. 
• The duration of psoriasis does not have any correlation with psychiatric 
morbidity. 
• Depression is found to be the common psychiatric diagnosis in Psoriasis. 
• Substance use disorders are prevalent in Psoriasis patients. 
• Number of life events and score in the past one year do not differ 
significantly in psoriatic patients with or without psychiatric morbidity. 
• Stressful life events are more in patients with psoriasis, especially events 
occurring within a year. 
• Overall, these results support the view that psychological stress plays a 
role in triggering or exacerbating psoriasis.  
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LIMITATIONS OF THE STUDY 
1. The major limitation of the study is the small sample size.  
2. The other limitation is the fact that this is a cross sectional analysis. 
3. Data regarding life events were collected after the incident. Distortion of 
life events due to time and recall bias is possible.  
4. Presumptive Stressful Life Events Scale picks up only certain life 
events. Everyday “Hassles” which may cause a significant life event, 
may not be scored in the life event scale.  
5. Follow up of the patients would help understanding the illness, its course 
and outcome. But, it could not be done because many of the patients did 
not turn up even though they were adequately informed for follow up. 
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PRACTICAL IMPLICATIONS 
1. The prevalence of psychiatric comorbidity and emerging evidence for 
stress-induced exacerbations of psoriasis has led to the development of 
psychosocial intervention as an important adjunctive therapy in the 
management of psoriasis. 
2. The psychotherapeutic modalities with evidence for significant clinical 
improvement include Hypnosis, Meditation, Cognitive-Behavioral 
Therapy and Guided Imagery Training. 
3. Psychological interventions can help individuals to reinterpret events 
and develop strategies to cope with stressful events, thus decreasing 
morbidity due to these diseases.  
4. There are only limited data on controlled trails of 
psychopharmacological treatments of anxiety and depression in psoriasis 
patients and its effect on the course of psoriasis. 
5. In psoriasis the severity of pruritus is associated with higher depression 
scores and a greater risk for suicide. An improvement in pruritus led to a 
decrease in depression scores. 
 
S.No Age Sex Religion Education Occupation FI SES Marital Status
1 4 1 1 5 3 5 3 2
2 4 1 1 7 6 5 4 2
3 2 2 1 6 6 4 4 4
4 4 1 1 6 6 6 4 2
5 2 1 1 6 5 5 4 2
6 4 1 1 6 5 6 4 2
7 3 1 1 6 5 5 4 2
8 3 1 1 5 3 5 3 2
9 2 1 1 6 3 5 4 2
10 4 1 1 6 3 5 4 2
11 3 1 1 6 3 5 4 2
12 4 1 1 6 3 5 4 2
13 2 1 1 4 4 3 3 2
14 2 1 1 4 4 4 3 2
15 2 1 1 5 3 4 3 2
16 3 1 1 5 3 5 3 2
17 2 1 1 3 4 3 3 2
18 3 1 1 5 3 3 3 2
19 3 1 1 5 3 3 3 2
20 3 1 1 5 5 4 4 2
21 3 1 1 6 6 4 4 2
22 2 1 1 5 6 4 4 2
23 3 1 1 6 3 5 4 2
24 2 2 1 5 5 4 4 2
25 3 1 1 6 4 3 3 2
26 2 2 1 6 6 5 4 2
27 3 1 1 5 3 4 3 2
28 3 2 1 5 6 5 4 2
29 2 1 1 4 4 3 3 2
30 3 1 1 7 6 3 4 2
31 3 2 1 5 3 4 3 2
32 2 2 1 6 5 4 4 2
33 3 1 1 6 3 4 3 2
34 2 1 1 4 3 4 3 2
35 2 1 2 6 5 5 4 2
36 3 1 1 5 3 5 3 2
37 3 2 1 6 6 5 4 2
38 2 1 1 6 5 4 4 2
39 3 1 1 5 3 3 3 2
40 2 2 1 3 4 3 3 2
41 3 2 1 5 5 4 4 2
42 3 1 1 6 6 5 4 2
43 3 1 1 6 3 5 4 2
44 3 1 1 5 5 4 4 2
45 3 2 1 6 5 5 4 2
S.No = Serial number
Age = 1) <18 years  2) 18-44 years  3) 45-64 years  4) >65 years
Sex = 1) male  2) female
Religion = 1) Hindu  2) Muslim  3) Christian  4) Others
Education = 1) Professional or Honours  2) Graduate or Post graduate  3) Intermediate or post hi
Occupation = 1)Profession  2) Semi Profession  3) Clerical, shop owner, farmer  4) Skilled worke
FI = Family income per month = 1) 19575  2) 9788-19574  3) 7323-9787  4) 4894-7322  5) 2936-4
SES = Socio-economic status = 1) Upper  2) Upper Middle  3) Lower Middle  4) Upper Lower  5) 
Marital status = 1) single  2) married  3) widowed  4) separated  5) divorced
Marital life = 1) cordial  2) satisfactory  3) Unsatisfactory  4) strained
Type of family = 1) nuclear  2) joint  3) extended  4) broken 
FH-MI = Family history of mental illness = 1) present  2) absent
FH-Pso = Family history of psoriasis =  1)present  2) absent
Age of onset in yrs = Age of onset of psoriasis in years
Duration in yrs = Duration of psoriasis in years
Pruritus = whether pruritus associated with psoriasis = 1) Yes  2) No
Pruritus 1  = If yes, does pruritis increases during stress?  = 1) Yes, increases   2) No, Not increa
Any other SLE = Any other stressful life events  within a year? = 1) Yes  2) No
HOS use = History of substance abuse = 1) present  2) absent
HOS - TOS = If present, type of substance = 1) Alcohol  2) Tobacco  3) Others  4) Multiple
HOS-when started = If present, when it has started = 1) Before the onset of illness  2) After the on
HOS-pattern = If present, pattern of use = 1) Occasional  2) Harmful use  3) Dependence
TOT = Type of treatment = 1) Topical steroids  2) PUVA  3) Methotrexate  4) Tazoretene  5) Othe
PSLES = Presumptive stressful life events scale (Gurmeet singh)
No of LE - lifetime = Total number of stressful Life Events during their lifetime
Lifetime - Score = Total score for stressful life events during their lifetime.
No of LE - previous 1 yr = Total number of stressful life events in the previous 1 year before the o
Score - previous 1 yr = Total score for stressful life events in the previous 1 year
HAM-D = Hamilton depression rating scale  = 1)  None/Minimal depression   2) Mild depression   
CPD =Current psychiatric diagnosis (using ICD-10) = 1)Yes  2) No
CPD 1 = If yes = 1) Depressive disorder  2) Anxiety disorder  3) Alcohol dependence  4) Alcohol h
PRESUMPTIVE STRESSFUL LIFE EVENTS SCALE (Gurmeet Singh
Rank Mean stress score
1    Death of spouse                                                    95
2 Extra-marital relation of spouse              80
3 Marital separation/divorce        77
4 Suspension or dismissal from job           76
5 Detention in jail of self or close family member  72
6 Lack of child                                                         67
7 Death of close family member        66
8 Marital conflict                64
9 Property or crops damaged       61
10 Death of friend                60
11 Robbery or theft         59
12 Excessive alcohol or drug use by family member 58
13 Conflict with in laws( other than over dowry)     57
Life Events
14 Broken engagements or love affairs       57
15    Major personal illness or injury            56
16 Son or daughter leaving home                              55
17    Financial loss or problems       54
18    Illness of family member                       52
19    Trouble at work with colleagues, superiors         52
20    Prophecy of astrologer or palmist etc                  52
21    Pregnancy of wife                                              52
22    Conflict over dowry                                            51
23    Sexual problems                                            51
24    Self or family member unemployed           51
25    Lack of son                                                           51
26    Large loan                                                            51
27 Marriage of daughter or dependent sister             49
28 Minor violation of law                                          48
29 Family conflict                                                     47
30 Break-up with friend                                            47
31 Major purchase or construction of house             46
32 Death of pet                                                   44
33 Failure in examination                                         43
34 Appearing for an examination or interview         43
35 Getting married or engaged                                  43
36 Trouble with neighbor                                    40
37 Unfulfilled commitments                                     40
38 Change in residence                                             39
39 Change or expansion of business                         37
40 Outstanding personal achievement                       37
41 Begin or end schooling                                         36
42 Retirement                                                            35
43 Change in working conditions/transfer                33
44 Change in sleeping habits                                     33
45 Birth of daughter                                                  30
46 Gain of new family member                                 30
47 Reduction in number of family function              29
48 Change in social activities                                    28
49 Change in eating habits                                        27
50 Wife begins or stops work                                    25
51 Going on pleasure trip or pilgrimage                   20
Marital Life Type of Family FH-MI FH-Pso Age of onset in yrs Duration in yrs Pruritus
2 1 2 2 60 5 1
1 1 2 2 63 2 1
4 4 2 2 32 5 1
2 1 2 2 68 2 1
2 1 2 2 36 4 1
2 1 2 2 60 7 1
2 1 2 2 45 25 2
1 1 1 2 30 30 1
2 1 2 2 37 7 1
2 2 2 2 64 1 1
2 1 1 2 44 11 1
2 1 2 1 65 1 1
1 1 2 1 28 14 1
3 1 2 2 28 1 1
2 1 2 2 38 2 1
2 1 2 2 53 7 2
2 1 1 2 32 1 1
2 1 2 2 40 10 1
1 1 2 1 56 3 1
1 1 2 2 47 10 1
2 1 2 2 45 10 1
1 1 2 2 37 7 1
2 1 2 2 45 15 1
4 4 2 2 32 10 2
2 1 2 2 40 5 2
3 1 2 2 35 3 1
4 4 2 2 39 11 1
2 2 2 2 30 15 1
1 1 2 1 30 13 1
2 2 2 2 55 5 1
1 1 2 2 48 5 1
2 4 2 2 30 5 1
1 1 2 1 45 15 1
2 1 2 2 29 3 1
2 1 2 2 37 7 1
2 1 2 2 51 7 2
2 1 2 2 46 2 1
2 2 2 2 36 4 1
1 1 2 1 54 3 1
1 1 1 2 32 3 1
3 1 2 2 49 7 1
2 1 2 2 40 5 1
2 2 2 2 52 7 1
1 1 2 2 36 10 1
3 1 2 1 30 15 1
gh school diploma  4) High school certificate  5) Middle school certificate  6) Primary school certificate  7
r  5) Semiskilled worker  6)Unskilled worker  7) Unemployed
4893  6) 980-2935  7) 979
Lower
ses
nset of illness
ers
onset or exacerbation of psoriasis 
3) Moderate depression   4)  severe depression
harmful use  5) Alcohol dependence and depressive disorder  6) Alcohol harmful use and depressive dis
h et al. 1984)


Pruritus 1 Any other SLE HOS use HOS - TOS HOS-when started HOS-pattern TOT
1 2 1 1 1 3 1
1 2 2 3
1 2 2 3
1 2 2 1
2 2 1 1 1 2 1
1 2 1 1 1 2 1
2 1 4 1 2 1
1 2 1 1 1 1 1
1 2 2 1
1 2 1 1 1 1 1
1 2 1 1 1 2 3
1 2 1 4 1 2 3
1 2 2 5
2 2 1 1 1 2 5
2 2 1 1 1 1 1
2 2 5
1 2 1 1 1 1 5
1 2 1 4 1 2 5
1 2 1 1 1 2 3
1 2 1 1 1 2 5
2 2 2 3
1 2 2 3
1 2 1 1 1 2 3
2 2 5
2 1 4 1 3 1
1 2 2 3
1 2 1 4 1 2 1
1 2 2 5
1 2 1 1 1 2 3
1 2 2 3
1 2 2 1
1 2 2 3
1 2 1 1 1 2 1
1 2 1 1 1 2 5
1 2 1 2 1 2 1
2 2 5
1 2 2 3
2 2 1 1 1 2 3
1 2 1 1 1 2 1
2 2 2 3
1 2 2 5
1 2 1 4 1 3 3
1 2 1 4 2 1 3
1 2 1 1 2 1 1
1 2 1 2 2 1 3
) illiterate
order   7) Others


HAM-D CPD 
No of LE - lifetime Lifetime - Score No of LE - previous 1 yr Score - previous 1 yr
8 359 2 95 3 1
5 260 2 99 3 1
6 311 1 39 4 1
3 111 0 0 2 2
6 247 2 99 1 1
6 266 2 72 1 1
10 449 2 99 1 1
3 100 0 0 2 1
4 191 4 191 1 2
7 372 2 106 2 1
5 228 3 163 1 1
4 154 1 66 2 1
6 259 2 105 1 1
2 122 2 122 2 1
3 140 0 0 1 2
5 206 2 105 1 2
4 216 2 110 1 2
6 297 1 54 2 1
4 182 2 103 1 1
5 233 3 161 2 1
5 202 2 105 2 1
3 146 0 0 1 2
4 180 1 58 1 1
6 259 1 54 2 1
5 253 2 101 1 1
6 354 2 144 1 2
9 448 0 0 1 1
3 148 1 55 1 2
7 317 2 90 2 1
5 227 2 96 4 1
4 186 1 52 1 2
PSLES
6 332 2 149 3 1
7 354 2 153 1 1
3 169 0 0 1 1
5 219 1 66 1 2
3 140 0 0 1 2
7 311 3 134 1 2
3 178 1 66 1 1
4 195 3 137 1 1
4 209 0 0 1 2
8 349 3 151 1 2
6 312 3 143 1 1
6 246 2 100 4 1
6 287 4 182 1 2
5 258 2 115 3 1



CPD 1
5
1
1
4
4
4
1
1
4
6
1
4
4
4
6
1
4
1
3
4
6
1
14
4
4
4
3
1
1
Appendix-I 
PROFORMA 
 Name: 
Address: 
Age: 1) <18years   2) 18-44years   3) 45-64years   4) >65years 
Sex:  1) male  2) female 
Religion:  1) Hindu   2) Muslim   3) Christian   4) others 
Education:  1) professional or Honours  2) graduate or post graduate   
3)Intermediate or post high school diploma  4) High school certificate  
5)Middle school certificate  6) Primary school certificate  7) Illiterate                                        
Occupation:  1) profession  2) Semi profession  3) Clerical, shop owner, farmer   
4) Skilled worker  5) Semiskilled worker  6) Unskilled worker  7) Unemployed  
Family income per month:  1) 19575   2)9788-19574   3) 7323-9787                      
4) 4894-7322   5) 2936-4893   6) 980-2935   7) 979 
Socio-economic status:  1) Upper  2) Upper Middle  3) Lower Middle                  
4) Upper Lower  5) Lower                             
Marital status:  1) single  2) married  3) widowed  4) Separated  5) divorced 
Marital life:  1) cordial  2) satisfactory  3) Unsatisfactory  4) strained 
Type of family:  1) nuclear  2) joint  3) extended  4) broken 
Family history of mental illness:  1) present  2) absent 
Family history of psoriasis:  1) present  2) absent 
Age of onset of psoriasis in years: 
Duration of psoriasis in years: 
Whether Pruritus associated with psoriasis:      1) Yes   2) No 
        If yes, is pruritus aggravated by stress  
1) Yes    2) No 
Any other stressful life events within a year?     1) Yes   2) No 
History of substance abuse:   1) present   2) absent 
 (a) If present, type of substance  
  1) Alcohol  2) Tobacco  3) Others  4) Multiple     
(b) If present, when it has started 
                 1)  Before the onset of illness   2) After the onset of illness. 
 (c) If present, pattern of use 
  1) Occasional  2) Harmful use  3) Dependence 
Type of treatment:    1) topical steroids   2) PUVA   3) Methotrexate   
4) Tazoretene   5) Others 
Presumptive Stressful Life Events Scale – PSLES (Gurmeet singh): 
1. Total number of stressful Life Events during their lifetime: 
2. Total score for stressful life events during their lifetime: 
3. Total number of stressful life events in the previous 1 year before the 
onset or exacerbation of psoriasis: 
4. Total score for stressful life events in the previous 1 year 
Hamilton Depression Rating Scale (HAM-D): 
1)  None/Minimal depression   2) Mild depression    
3) Moderate depression   4) Severe depression 
Current psychiatric diagnosis (using ICD-10 diagnostic criteria) 
1) Yes   2) No 
If yes, (CPD 1) 
                    1) Depressive disorder  2) Anxiety disorder   3) Alcohol 
dependence   4) Alcohol harmful use   5) Alcohol dependence and depressive 
disorder  6) Alcohol harmful use and depressive disorder  7) Others 
 
 
 
 
 
 
 
 
 
 
APPENDIX-II 
HAMILTON DEPRESSION RATING SCALE (17 ITEMS SCALE) 
1. Depressed Mood (sadness, hopeless, helpless, worthless) 
0 = Absent 
1 = These feeling states indicated only on questioning 
2 = These feeling states spontaneously reported verbally 
3 = Communicates feeling states nonverbally (i.e., through facial expression, 
posture, voice, and tendency to weep) 
4 = Patient reports virtually only these feeling states in his spontaneous verbal 
and nonverbal communication 
2. Feelings of Guilt 
0 = Absent 
1 = Self-reproach, feels he has let people down 
2 = Ideas of guilt or rumination over past errors or sinful deeds 
3 = Present illness is a punishment. Delusions of guilt 
4 = Hears accusatory or denunciatory voices and/or experiences threatening 
visual hallucinations 
3. Suicide 
0 = Absent 
1 = Feels life is not worth living 
2 = Wishes he were dead or any thoughts of possible death to self 
3 = Suicide ideas or gesture 
4 = Attempts at suicide (any serious attempt rates 4) 
4. Insomnia Early 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep (e.g., more than 1/2 hour) 
2 = Complains of nightly difficulty falling asleep 
5. Insomnia Middle 
0 = No difficulty 
1 = Patient complains of being restless and disturbed during the night 
2 = Waking during the night – any getting out of bed rates 2 (except for 
purposes of voiding) 
6. Insomnia Late 
0 = No difficulty 
1 = Waking in early hours of the morning but goes back to sleep 
2 = Unable to fall asleep again if he gets out of bed 
7. Work and Activities 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, fatigue, or weakness related to 
activities, work, or hobbies 
2 = Loss of interest in activity; hobbies or work – either directly reported by 
patient, or indirect in listlessness, indecision and vacillation (feels he has to 
push self to work or activities) 
3 = Decrease in actual time spent in activities or decrease in productivity. In 
hospital, rate 3 if patient does not spend at least 3 hours a day in activities 
(hospital job or hobbies) exclusive of ward chores 
4 = Stopped working because of present illness. In hospital, rate 4 if patient 
engages in no activities except ward chores, or if patient fails to perform ward 
chores unassisted 
8. Retardation (slowness of thought and speech: impaired ability to 
concentrate, decreased motor activity) 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = Interview difficult 
4 = Complete stupor 
9. Agitation 
0 = None 
1 = Fidgetiness 
2 = Playing with hands, hair, etc 
3 = Moving about, can’t sit still 
4 = Hand wringing, nail biting, hair-pulling, biting of lips 
10. Anxiety Psychic 
0 = No difficulty 
1 = Subjective tension and irritability 
2 = Worrying about minor matters 
3 = Apprehensive attitude apparent in face or speech 
4 = Fears expressed without questioning 
11. Anxiety Somatic 
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
12. Somatic Symptoms – Gastro-intestinal 
0 = None 
1 = Loss of appetite but eating without staff encouragement. Heavy feelings in 
abdomen 
2 = Difficulty eating without staff urging. Requests or requires laxatives or 
medication for bowels or medication for GI symptoms 
 
13. Somatic Symptoms General 
0 = None 
1 = Heaviness in limbs, back, or head. Backaches, headaches, muscle aches. 
Loss of energy and fatigability 
2 = any clear-cut symptoms rates 2 
14. Genital Symptoms 
Symptoms such as: Loss of libido, menstrual disturbances 
0 = Absent 
1 = Mild 
2 = Severe 
15. Hypochondriasis 
0 = Not present 
1 = Self-absorption (bodily) 
2 = Preoccupation with health 
3 = Frequent complaints, requests for help, etc 
4 = Hypochondriacal delusions 
16. Loss of Weight 
0 = No weight loss 
1 = Probable weight loss associated with present illness 
2 = Definite (according to patient) weight loss 
17. Insight 
0 = Acknowledges being depressed and ill 
1 = Acknowledges illness but attributes cause to bad food, climate, overwork, 
virus, need for rest, etc 
2 = Denies being ill at all 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX-III 
PRESUMPTIVE STRESSFUL LIFE EVENTS SCALE  
(Gurmeet Singh et al. 1984) 
Rank Life Event One year 
Life 
Time 
01 Death of spouse (95)   
02 Extra-marital relation of spouse (80)   
03 Marital separation/divorce (77)   
04 Suspension or dismissal from job (76)   
05 Detention in jail of self or close family member (72)   
06 Lack of child (67)   
07 Death of close family member (66)   
08 Marital conflict (64)   
09 Property or crops damaged (61)   
10 Death of a friend (60)   
11 Robbery or theft (59)   
12 Excessive alcohol or drug use by family member (58)   
13 Conflict with in laws (other than over dowry) (57)   
14 Broken engagements or love affairs (57)   
15 Major personal illness or injury (56)   
16 Son or daughter leaving home (55)    
17 Financial loss or problems (54)   
18 Illness of family member (52)   
19 Trouble at work with colleagues, superiors (52)   
20 Prophecy of astrologer or palmist etc (52)   
21 Pregnancy of wife (52)   
22 Conflict over dowry (51)   
23 Sexual problems (51)   
24 Self or family member unemployed (51)   
25 Lack of son (51)   
26 Large loan (51)   
27 Marriage of daughter or dependent sister (49)   
28 Minor violation of law (48)   
29 Family conflict (47)   
30 Break-up with friend (47)   
31 Major purchase or construction of house (46)   
32 Death of pet (44)   
33 Failure in examination (43)   
34 Appearing for an examination or interview (43)   
35 Getting married or engaged (43)   
36 Trouble with neighbor (40)   
37 Unfulfilled commitments (40)   
38 Change in residence (39)   
39 Change or expansion of business (37)   
40 Outstanding personal achievement (37)   
41 Begin or end schooling (36)   
42 Retirement (35)   
43 Change in working conditions/transfer (33)   
44 Change in sleeping habits (33)   
45 Birth of daughter (30)   
46 Gain of new family member (30)   
47 Reduction in number of family function (29)   
48 Change in social activities (28)   
49 Change in eating habits (27)   
50 Wife begins or stops work (25)   
51 Going on pleasure trip or pilgrimage (20)   
 
Total number of life events (one year): 
Life events score (one year): 
Total number of life events (life time): 
Life events score (life time) 
 
APPENDIX-IV 
MODIFIED KUPPUSWAMY SCALE FOR SOCIO ECONOMIC 
STATUS (updated by N.Kumar, C.Shekhar, 2007) 
 
Education Educational Level Score 
  
  
  
  
  
Professional / Honours 7 
Graduate/Postgraduate 6 
Intermediate / Post High school diploma 5 
High School 4 
Middle School 3 
Primary school / Literate 2 
Illiterate 1 
Occupation Type of occupation   
  
  
  
  
  
Profession 10 
Semi profession 6 
Clerical, Shop owner, Farmer 5 
Skilled worker 4 
Semi-skilled worker 3 
Unskilled worker 2 
Unemployed 1 
Income Family income per month   
  
  
  
  
  
Year-1976 Year-2005   
>2000 >17520 12 
1000-1999 8760-17515 10 
750-749 6570-8750 6 
500-749 4380-6560 4 
300-499 2628-4370 3 
101-299 885-2620 2 
<100 <876 1 
 
 
Total Score: 
Score Socio Economic Class 
26-29 Upper Upper I 
16-25 
Middle 
Upper middle II 
11-15 Lower middle III 
5-10 
Lower 
Upper lower IV 
<5 Lower V 
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